Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment.

Trial Profile

Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2012

At a glance

  • Drugs Ezetimibe (Primary) ; Simvastatin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms PLAUDIT
  • Most Recent Events

    • 25 Feb 2011 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
    • 25 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top